ESPA STOCK BIOTEC

Global biotech companies with a focus on the USA
ISIN: AT0000A0XYP0  

 
Performance goal and investment strategy
The <> fund invests in the most important biotech companies, primarily those in the USA. Equities from the Pacific region and Europe play a minor role, but are also selectively added to the fund. The currencies are not hedged against the euro. The fund is particularly suitable as an addition to an existing equity portfolio and is geared towards achieving long-term capital appreciation.
 
Performance (2019/11/29)
Period
YTD
6m
1Y
(% p a)
3Y
(% p a)
5Y
(% p a)
10Y
(% p a)
since inc.
(% p a)
Perf 31.55 - 14.58 5.90 5.11 - 17.61
Annual performance in % (2019/11/29)
Period 2014 2015 2016 2017 2018
Perf 54.28 20.88 -18.75 4.26 -8.63
Minimum & maximum performance in % p.a. (2019/11/29)
1Y
117.38
-51.90
3Y
52.56
-22.95
5Y
42.14
-9.64
10Y
21.55
-4.24
 
 
Disclaimer
Full names of open Mutual funds are given in the fund statutes (prospectuses). Pursuant to rules applicable to collective investment, the manager informs that neither the current or expected performance will guarantee the future performance. Investment in investment certificates contains the risk that the current value of amount invested and yields on the amount will fluctuate; thus return on the amount invested is not guaranteed. All information provided herein is of informative nature only and it should not substitute the statute (prospectus) or give its overall summary. Before using this website/information for investment, you should consult consultants of Česká spořitelna. If any yield is mentioned in the reference material, you should always bear in mind that past yields will not guarantee future yields, that any investment is subject to the risk of value fluctuations and change of exchange rates, and that return on the amount invested or profit margin cannot be guaranteed.